Improved survival outcomes and restoration of graft‐vs‐leukemia effect by deferasirox after allogeneic stem cell transplantation in acute myeloid leukemia

Deferasirox is an oral iron‐chelating agent having possible antileukemia and immune modulatory effects. Few reports have evaluated deferasirox in the setting of allogeneic hematopoietic stem cell transplantation (allo‐HSCT). We investigated the impact of deferasirox after allo‐HSCT in acute myeloid...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:Cancer Med
Main Authors: Cho, Byung‐Sik, Jeon, Young‐Woo, Hahn, A‐Reum, Lee, Tai‐Hyang, Park, Sung‐Soo, Yoon, Jae‐Ho, Lee, Sung‐Eun, Eom, Ki‐Seong, Kim, Yoo‐Jin, Lee, Seok, Min, Chang‐Ki, Cho, Seok‐Goo, Lee, Jong‐Wook, Min, Woo‐Sung, Kim, Hee‐Je
Formato: Artigo
Idioma:Inglês
Publicado em: John Wiley and Sons Inc. 2019
Assuntos:
Clinical Cancer Research
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC6382990/
https://ncbi.nlm.nih.gov/pubmed/30677244
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1002/cam4.1928
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados